Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclib

  • R. Costa
  • , R. B. Costa
  • , Sarah M. Talamantes
  • , Irene Helenowski
  • , Jonna Peterson
  • , Jason Kaplan
  • , B. A. Carneiro
  • , Francis J. Giles
  • , W. J. Gradishar

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalBreast
Volume35
DOIs
StatePublished - Oct 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Surgery
  • Oncology
  • Cancer Research

Keywords

  • Infection
  • Neutropenia
  • Palbociclib
  • Ribociclib

Cite this